Advancing Small Molecule Therapies to Target MUC1-C in Cancer
- Therapeutics
- 2025
All Accelerator Awardees
Explore the innovative work of Dana-Farber Accelerator Award winners in diagnostics and therapeutics, and learn how their groundbreaking research is shaping the future of cancer care.
Showing 1-12 of 13
Manipulating the Immunopeptidome for Rapid Tumor Elimination
- Therapeutics
- 2025
Classification Tool for Diffuse Large B Cell Lymphoma to Guide Treatment and Improve Prognostic Accuracy
- Diagnostics
- 2025
Natural Killer Cell Clinical Trial Aims to Eradicate Residual Disease in Leukemia Patients
- Therapeutics
- 2024
Innovative Inhibitors of Creatine Kinase Pathway Metabolism Offer New Hope for Colon Cancer Therapy
- Therapeutics
- 2024
New Therapies Focus on “Undruggable” Targets in Intrinsically Discovered Regions in Cancer
- Therapeutics
- 2024
Restoring the guardian: p53 tumor suppression without toxicity
- Therapeutics
- 2023
Fast and furious: Next-generation targeted protein degradation
- Therapeutics
- 2023
Empowering natural killer cells to seek and destroy
- Therapeutics
- 2023
Unlocking the immune system as a sensor for early cancer detection
- Diagnostics
- 2023
